Cargando…

Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing

The National Institute of Allergy and Infectious Diseases (NIAID) Virology Quality Assurance (VQA) established a robust proficiency testing program for Sanger sequencing (SS)-based HIV-1 drug resistance (HIVDR) testing in 2001. While many of the lessons learned during the development of such program...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jennings, Cheryl, Parkin, Neil T., Zaccaro, Daniel J., Capina, Rupert, Sandstrom, Paul, Ji, Hezhao, Brambilla, Donald J., Bremer, James W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766986/ https://www.ncbi.nlm.nih.gov/pubmed/33348705 http://dx.doi.org/10.3390/v12121456

Ejemplares similares

External Quality Assessment Program for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Logistical Considerations
por: Ji, Hezhao, et al.
Publicado: (2020)

Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance Genotyping
por: Parkin, Neil T., et al.
Publicado: (2020)

Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing
por: Lee, Emma R., et al.
Publicado: (2020)

Point-of-Care Tests for HIV Drug Resistance Monitoring: Advances and Potentials
por: Chua, Rayeil J., et al.
Publicado: (2022)

Bioinformatic data processing pipelines in support of next‐generation sequencing‐based HIV drug resistance testing: the Winnipeg Consensus
por: Ji, Hezhao, et al.
Publicado: (2018)

A Comparison of Parallel Pyrosequencing and Sanger Clone-Based Sequencing and Its Impact on the Characterization of the Genetic Diversity of HIV-1
por: Liang, Binhua, et al.
Publicado: (2011)

External Quality Assessment for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Unique Requirements and Challenges
por: Lee, Emma R., et al.
Publicado: (2020)

Prevalence of Primary Drug Resistance Against HIV-1 Integrase Inhibitors in Canada
por: Ji, Hezhao, et al.
Publicado: (2018)

Genetic Testing Requires NGS and Sanger Methodologies
por: Jennings, Lawrence J., et al.
Publicado: (2016)

Development and Application of Performance Assessment Criteria for Next-Generation Sequencing-Based HIV Drug Resistance Assays
por: Becker, Michael G., et al.
Publicado: (2020)

A MiSeq-HyDRA platform for enhanced HIV drug resistance genotyping and surveillance
por: Taylor, Tracy, et al.
Publicado: (2019)

The Antibody Genetics of Multiple Sclerosis: Comparing Next-Generation Sequencing to Sanger Sequencing
por: Rounds, William H., et al.
Publicado: (2014)

SangeR: the high-throughput Sanger sequencing analysis pipeline
por: Schmid, Kai, et al.
Publicado: (2022)

Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations
por: Ávila-Ríos, Santiago, et al.
Publicado: (2020)

qSanger: Quantification of Genetic Variants in Bacterial Cultures by Sanger Sequencing
por: Prakash, Satya, et al.
Publicado: (2023)

Robert M. Sanger
Publicado: (1911)

Professor Max Sänger
Publicado: (1903)

Sänger’s Cæsarean Operation
Publicado: (1886)

Performance evaluation of Sanger sequencing for the diagnosis of primary hyperoxaluria and comparison with targeted next generation sequencing
por: Williams, Emma L, et al.
Publicado: (2015)

Replacing Sanger with Next Generation Sequencing to improve coverage and quality of reference DNA barcodes for plants
por: Wilkinson, Mike J., et al.
Publicado: (2017)

Sanger and Next Generation Sequencing Approaches to Evaluate HIV-1 Virus in Blood Compartments
por: Arias, Andrea, et al.
Publicado: (2018)

Quality assurance for HIV point-of-care testing and treatment monitoring assays
por: Meyers, Adrienne F.A., et al.
Publicado: (2016)

Cortinarius subgenus Leprocybe in Europe: expanded Sanger and Next Generation Sequencing unveil unexpected diversity in the Mediterranean
por: Bidaud, A., et al.
Publicado: (2021)

Comparison of Targeted Next-Generation and Sanger Sequencing for the BRCA1 and BRCA2 Mutation Screening
por: Park, Joonhong, et al.
Publicado: (2016)

Clinical Use of a 16S Ribosomal RNA Gene-Based Sanger and/or Next Generation Sequencing Assay to Test Preoperative Synovial Fluid for Periprosthetic Joint Infection Diagnosis
por: Flurin, Laure, et al.
Publicado: (2022)

Pioneer of the future: Margaret Sanger
Publicado: (1978)

Frederick Sanger (1918–2013)
por: Roe, Bruce A.
Publicado: (2014)

A14 Estimating time since HIV infection using next-generation sequencing data: A unique tool to help understand HIV prevention among high-risk young women in Ukraine
por: Cholette, Francois, et al.
Publicado: (2019)

Dry Panels Supporting External Quality Assessment Programs for Next Generation Sequencing-Based HIV Drug Resistance Testing
por: Noguera-Julian, Marc, et al.
Publicado: (2020)

Use of sanger and next-generation sequencing to screen for mosaic and intronic APC variants in unexplained colorectal polyposis patients
por: Elsayed, Fadwa A., et al.
Publicado: (2021)

Added Value of Next Generation over Sanger Sequencing in Kenyan Youth with Extensive HIV-1 Drug Resistance
por: Novitsky, V., et al.
Publicado: (2022)

Overview of the Analytes Applied in Genotypic HIV Drug Resistance Testing
por: Ji, Hezhao, et al.
Publicado: (2022)

SARS Molecular Detection External Quality Assurance
por: Drosten, Christian, et al.
Publicado: (2004)

Sanger and Next-Generation Sequencing data for characterization of CTL epitopes in archived HIV-1 proviral DNA
por: Tumiotto, Camille, et al.
Publicado: (2017)

EHPnet: Wellcome Trust Sanger Institute
por: Dooley, Erin E.
Publicado: (2006)

Development of an international external quality assurance program for HIV-1 incidence using the Limiting Antigen Avidity assay
por: Keating, Sheila M., et al.
Publicado: (2019)

Are We Ready for NGS HIV Drug Resistance Testing? The Second “Winnipeg Consensus” Symposium
por: Ji, Hezhao, et al.
Publicado: (2020)

A Sequel to Sanger: amplicon sequencing that scales
por: Hebert, Paul D. N., et al.
Publicado: (2018)

Quality Control of Next-Generation Sequencing-Based HIV-1 Drug Resistance Data in Clinical Laboratory Information Systems Framework
por: Capina, Rupert, et al.
Publicado: (2020)

Comparison of targeted next-generation sequencing and Sanger sequencing for the detection of PIK3CA mutations in breast cancer
por: Arsenic, Ruza, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0sp2d0blru60dr8agbje4vk6gf